クリングルファーマ株式会社.

NEWS

お知らせ


Warning: Invalid argument supplied for foreach() in /home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line 21
2008.10.01

IND for ARF Phase Ia PDF

Kringle Pharma Files IND Application to FDA to Conduct Studies on recombinant human HGF for the Treatment of ARF.